Answers are grounded in this paper and cite their sources.
National Cancer Institute Designated Cancer Centers are expected to ensure that clinical research portfolios reflect the cancer burden and needs of their catchment area. Achieving this expectation can be enhanced through effective collaboration between the Community Outreach and Engagement (COE) and Clinical Protocol and Data Management (CPDM) teams, which bring complementary expertise related to catchment area population characteristics and clinical trial operations. However, the literature lacks descriptions of specific, scalable strategies that cancer centers can use to achieve this goal. This article describes three data-driven strategies codeveloped by COE and CPDM teams implemented at Moffitt Cancer Center including: 1) identifying trial portfolio gaps, 2) supporting investigator-initiated trial eligibility development, and 3) determining realistic targets for trial feasibility. The strategies integrate routinely collected data into clinical trial portfolio assessment and planning processes, providing structured approaches to identify gaps in trial availability, informing clinical trial design and feasibility. These strategies may be adaptable at other cancer centers seeking to improve responsiveness to the cancer burden of the catchment area they serve.
No takes yet. Share an insight, caveat, or question.
Amorrortu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: